These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 33632120)

  • 1. Novel targeted therapies for Parkinson's disease.
    Ntetsika T; Papathoma PE; Markaki I
    Mol Med; 2021 Feb; 27(1):17. PubMed ID: 33632120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.
    Polissidis A; Petropoulou-Vathi L; Nakos-Bimpos M; Rideout HJ
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in Parkinson's disease: rationale and current status.
    Feng LR; Maguire-Zeiss KA
    CNS Drugs; 2010 Mar; 24(3):177-92. PubMed ID: 20155994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-based therapies in Parkinson's disease.
    Allen PJ; Feigin A
    Neurotherapeutics; 2014 Jan; 11(1):60-7. PubMed ID: 24129887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease modifying therapies III: Novel targets.
    Vijiaratnam N; Foltynie T
    Neuropharmacology; 2021 Dec; 201():108839. PubMed ID: 34656651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic targets for Parkinson's disease.
    Stoessl J
    Expert Opin Ther Targets; 2008 Apr; 12(4):425-36. PubMed ID: 18348679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Parkinson's disease : what's on the horizon?
    Wu SS; Frucht SJ
    CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
    Ciceri F; Rotllant D; Maes T
    Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old and new challenges in Parkinson's disease therapeutics.
    Pires AO; Teixeira FG; Mendes-Pinheiro B; Serra SC; Sousa N; Salgado AJ
    Prog Neurobiol; 2017 Sep; 156():69-89. PubMed ID: 28457671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions.
    Soreq L; Bergman H; Israel Z; Soreq H
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1086-93. PubMed ID: 24040822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in dopaminergic strategies for the treatment of Parkinson's disease.
    Mao Q; Qin WZ; Zhang A; Ye N
    Acta Pharmacol Sin; 2020 Apr; 41(4):471-482. PubMed ID: 32112042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying strategies for Parkinson's disease.
    Kalia LV; Kalia SK; Lang AE
    Mov Disord; 2015 Sep; 30(11):1442-50. PubMed ID: 26208210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
    Korecka JA; Verhaagen J; Hol EM
    Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy: a viable therapeutic strategy for Parkinson's disease?
    Berry AL; Foltynie T
    J Neurol; 2011 Feb; 258(2):179-88. PubMed ID: 20963433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.
    Li S; Dong J; Cheng C; Le W
    J Neural Transm (Vienna); 2016 Nov; 123(11):1279-1299. PubMed ID: 27515029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020.
    McFarthing K; Buff S; Rafaloff G; Dominey T; Wyse RK; Stott SRW
    J Parkinsons Dis; 2020; 10(3):757-774. PubMed ID: 32741777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting delivery in Parkinson's disease.
    Newland B; Dunnett SB; Dowd E
    Drug Discov Today; 2016 Aug; 21(8):1313-20. PubMed ID: 27312875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's in the pipeline for the treatment of Parkinson's disease?
    Sommer DB; Stacy MA
    Expert Rev Neurother; 2008 Dec; 8(12):1829-39. PubMed ID: 19086879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Parkinson's disease: Advances and strategies.
    Delenclos M; Jones DR; McLean PJ; Uitti RJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: gene therapies.
    Coune PG; Schneider BL; Aebischer P
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a009431. PubMed ID: 22474617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.